Existing studies have highlighted several c-RAF PPIs that promote cancer cell survival through suppression of pro-apoptotic signaling (e.g., ASK1, MST2, Bcl-2) and regulation of cell motility/de-differentiation (e.g., ROKα)10–12. The gene discussed is MAP3K5; the disease is cancer.